A role for the scaffolding adapter GAB2 in breast cancer

Nature Medicine

Volumn 12, Issue 1, 2006, Pages 114-121

  Bentires Alj, Mohamed ^a,b   Gil, Susana G ^a   Chan, Richard ^a   Wang, Zhigang C ^c   Wang, Yongping ^a   Imanaka, Naoko ^a   Harris, Lyndsay N ^d   Richardson, Andrea ^c   Neel, Benjamin G ^a   Gu, Haihua ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GRB2 ASSOCIATED BINDING PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; BREAST CELL; CARCINOGENESIS; CELL CULTURE; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE; CELL LINE, TUMOR; CHROMOSOME MAPPING; CROSSES, GENETIC; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KI-67 ANTIGEN; MALE; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; PHENOTYPE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR, ERBB-2; RETROVIRIDAE; TIME FACTORS;

ANIMALIA;

EID: 30044434225     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1341     Document Type: Article

References (47)

1. Bissell, M.J. & Radisky, D. Putting tumours in context. Nat. Rev. Cancer 1, 46-54 (2001).
2. Schlessinger, J. & Lemmon, M.A. SH2 and PTB domains in tyrosine kinase signaling. Sci. STKE 191, RE12 (2003).
3. Liu, Y. & Rohrschneider, L.R. The gift of Gab. FEBS Lett. 515, 1-7 (2002).
4. Gu, H. & Neel, B.G. The "Gab" in signal transduction. Trends Cell Biol. 13, 122-130 (2003).
5. Gu, H. et al. Essential role for Gab2 in the allergic response. Nature 412, 186-190 (2001).
6. Gu, H., Botelho, R.J., Yu, M., Grinstein, S. & Neel, B.G. Critical rale for scaffolding adapter Gab2 in Fc gamma R-mediated phagocytosis. J. Cell Biol. 161, 1151-1161 (2003).
7. Kong, M., Mounier, C., Dumas, V. & Posner, B.I. Epidermal growth factor-induced DNA synthesis. Key role for Src phosphorylation of the docking protein Gab2. J. Biol. Chem. 278, 5837-5844 (2003).
8. Nishida, K. et al. Requirement of Gab2 for mast cell development and KitL/c-Kit signaling. Blood 99, 1866-1869 (2002).
9. Wada, T. et al. The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis. Nat. Med. 11, 394-399 (2005).
10. Sattler, M. et al. Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell 1, 479-492 (2002).
11. Ischenko, I., Petrenko, O., Gu, H. & Hayman, M.J. Scaffolding protein Gab2 mediates fibroblast transformation by the SEA tyrosine kinase. Oncogene 22, 6311-6318 (2003).
12. Samuels, Y. et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554 (2004).
13. Feng, G.S. Shp-2 tyrosine phosphatase: signaling one cell or many. Exp. Cell Res. 253, 47-54 (1999).
14. Neel, B.G., Gu, H. & Pao, L. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28, 284-293 (2003).
15. Tartaglia, M. et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat. Genet. 34, 148-150 (2003).
16. Bentires-Alj, M. et al. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 64, 8816-8820 (2004).
17. Mohi, M.G. et al. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell 7, 179-191 (2005).
18. Daly, R.J. et al. The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer. Oncogene 21, 5175-5181 (2002).
19. Yamada, K., Nishida, K., Hibi, M., Hirano, T. & Matsuda, Y. Comparative FISH mapping of Gab1 and Gab2 genes in human, mouse and rat. Cytogenet. Cell Genet. 94, 39-42 (2001).
20. Ormandy, C.J., Musgrove, E.A., Hui, R., Daly, R.J. & Sutherland, R.L. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res. Treat. 78, 323-335 (2003).
21. Bekri, S. et al. Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma. Cytogenet. Cell Genet. 79, 125-131 (1997).
22. Slamon, D.J. et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med. 344, 783-792 (2001).
23. Muller, W.J., Sinn, E., Pattengale, P.K., Wallace, R. & Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54, 105-115 (1988).
24. Bouchard, L., Lamarre, L., Tremblay, P.J. & Jolicoeur, P. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57, 931-936 (1989).
25. Debnath, J. et al. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111, 29-40 (2002).
26. Mills, K.R., Reginato, M., Debnath, J., Queenan, B. & Brugge, J.S. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proc. Natl. Acad. Sci. USA 101, 3438-3443 (2004).
27. Dankort, D. et al. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol. Cell. Biol. 21, 1540-1551 (2001).
28. Dankort, D., Jeyabalan, N., Jones, N., Dumont, D.J. & Muller, W.J. Multiple ErbB-2/Neu phosphorylation sites mediate transformation through distinct effector proteins. J. Biol. Chem. 276, 38921-38928 (2001).
29. Songyang, Z. et al. SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778 (1993).
30. Lock, L.S., Royal, I., Naujokas, M.A. & Park, M. Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases. J. Biol. Chem. 275, 31536-31545 (2000).
31. Muthuswamy, S.K., Li, D., Lelievre, S., Bissell, M.J. & Brugge, J.S. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat. Cell Biol. 3, 785-792 (2001).
32. Yu, Q., Geng, Y. & Sicinski, P. Specific protection against breast cancers by cyclin D1 ablation. Nature 411, 1017-1021 (2001).
33. Matros, E. et al. BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res. Treat. 91, 179-186 (2005).
34. Richardson, A. et al. Specific contributions by X chromosomal abnormalities to basal-like, human breast cancer. Cancer Cell (in the press).
35. Shaulian, E. & Karin, M. AP-1 in cell proliferation and survival. Oncogene 20, 2390-2400 (2001).
36. Aronheim, A. et al. Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell 78, 949-961 (1994).
37. Chan, R.J. et al. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor. Blood 105, 3737-3742 (2005).
38. Balasenthil, S. et al. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J. Biol. Chem. 279, 1422-1428 (2004).
39. Reyal, F. et al. Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes - a study of 130 invasive ductal breast carcinomas. Cancer Res. 65, 1376-1383 (2005).
40. Wang, R.A., Mazumdar, A., Vadlamudi, R.K. & Kumar, R. P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium. EMBO J. 21, 5437-5447 (2002).
41. Bautista, S. & Theillet, C. CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei. Genes Chromosom. Cancer 22, 268-277 (1998).
42. Huang, E. et al. Gene expression predictors of breast cancer outcomes. Lancet 361, 1590-1596 (2003).
43. Gu, H., Pratt, J.C., Burakoff, S.J. & Neel, B.G. Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol. Cell 2, 729-740 (1998).
44. Gu, H. et al. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol. Cell. Biol. 20, 7109-7120 (2000).
45. Debnath, J., Muthuswamy, S.K. & Brugge, J.S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268 (2003).
46. Brummelkamp, T.R., Bernards, R. & Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243-247 (2002).
47. Gil-Henn, H. & Elson, A. Tyrosine phosphatase-epsilon activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells. J. Biol. Chem. 278, 15579-15586 (2003).